Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy

Authors
Publication date
1 January 2018
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    In Italy, there is scarce evidence on the epidemiological and economic burden induced by primary antibody deficiencies

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Cineca Institutional Research Information System

      redirect
      oaioai:art.torvergata.it:2108/219...
      Last time updated on 17/04/2020

      Archivio della ricerca - Università degli studi di Napoli Federico II

      redirect
      oaioai:www.iris.unina.it:11588/72...
      Last time updated on 19/04/2019

      Kingston University Research Repository

      redirect
      oaioai:eprints.kingston.ac.uk:420...
      Last time updated on 12/01/2019

      Archivio istituzionale della ricerca - Università di Padova

      redirect
      oaioai:www.research.unipd.it:1157...
      Last time updated on 16/01/2019

      Crossref

      redirect
      Last time updated on 04/12/2019

      Archivio istituzionale della ricerca - Università di Bari

      redirect
      oaioai:ricerca.uniba.it:11586/221...
      Last time updated on 06/01/2019

      ART

      redirect
      oaioai:art.torvergata.it:2108/219...
      Last time updated on 29/03/2020